Can Cardiac Resynchronization Therapy Use be Expanded?

    loading  Checking for direct PDF access through Ovid

Abstract

Dr. DiMarco does research for Medtronic, is a consultant for Medtronic, Novartis, and St. Jude, and is a speaker for Boston Scientific.

SOURCE:

Thibault B, et al. Cardiac resynchronization therapy in patients with heart failure and a QRS complex < 120 milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial. Circulation 2013; 127:873-881.ThibaultBet alCardiac resynchronization therapy in patients with heart failure and a QRS complex 120 milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure LESSEREARTH Trial.Circulation2013127873881

Related Topics

    loading  Loading Related Articles